We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IRWD market cap is 1.12B. The company's latest EPS is USD -6.3051 and P/E is -1.11.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 104.06M | 107.38M | 113.74M | 117.55M | 74.88M |
| Operating Income | 60.1M | -1.08B | 40.02M | 37.59M | 11.02M |
| Net Income | 45.71M | -1.06B | 15.32M | -1.09M | -4.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 431.94M | 389.52M | 413.8M | 410.6M | 442.74M |
| Operating Income | 116.95M | 142.94M | 232.26M | 250.34M | -945.43M |
| Net Income | 21.51M | 106.18M | 528.45M | 175.07M | -1B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.16B | 603.22M | 524.06M | 471.07M | 438.82M |
| Total Liabilities | 448.43M | 950M | 849.74M | 817.37M | 769.34M |
| Total Equity | 706.85M | -346.78M | -325.68M | -346.3M | -330.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 402.75M | 559.24M | 1.13B | 1.1B | 471.07M |
| Total Liabilities | 496M | 496.6M | 521.02M | 448.14M | 817.37M |
| Total Equity | -93.25M | 62.64M | 605.91M | 652.38M | -346.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 80.17M | 115.13M | 147.59M | 183.43M | 44.99M |
| Investing | -13k | -999.51M | -1.02B | -1.03B | -68k |
| Financing | 3.98M | 403.05M | 328.06M | 277.16M | -15.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.73M | 168.84M | 261.9M | 273.76M | 183.43M |
| Investing | -11.14M | -1.84M | -265k | -136k | -1.03B |
| Financing | -1.19M | 18.55M | -4.55M | -237.55M | 277.16M |
| Market Cap | 1.12B |
| Price to Earnings Ratio | -1.11 |
| Price to Sales Ratio | 2.52 |
| Price to Cash Ratio | 12.13 |
| Price to Book Ratio | -3.23 |
| Dividend Yield | - |
| Shares Outstanding | 158.96M |
| Average Volume (1 week) | 1.63M |
| Average Volume (1 Month) | 1.54M |
| 52 Week Change | -33.40% |
| 52 Week High | 15.70 |
| 52 Week Low | 5.47 |
| Spread (Intraday) | 0.46 (6.42%) |
| Company Name | Ironwood Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ironwoodpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
